EyePoint Pharmaceuticals Inc (EYPT)
11.72
-0.34
(-2.82%)
USD |
NASDAQ |
Nov 04, 12:58
EyePoint Pharmaceuticals Shareholders Equity (Quarterly): 228.30M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 228.30M |
March 31, 2024 | 249.93M |
December 31, 2023 | 266.32M |
September 30, 2023 | 58.62M |
June 30, 2023 | 57.26M |
March 31, 2023 | 78.39M |
December 31, 2022 | 96.37M |
September 30, 2022 | 136.35M |
June 30, 2022 | 151.37M |
March 31, 2022 | 166.82M |
December 31, 2021 | 184.38M |
September 30, 2021 | 92.75M |
June 30, 2021 | 106.86M |
March 31, 2021 | 115.71M |
December 31, 2020 | 18.54M |
September 30, 2020 | 7.594M |
June 30, 2020 | 4.188M |
March 31, 2020 | 16.47M |
December 31, 2019 | 8.33M |
September 30, 2019 | 15.94M |
June 30, 2019 | 28.21M |
March 31, 2019 | 19.88M |
September 30, 2018 | 47.70M |
June 30, 2018 | 11.69M |
March 31, 2018 | 8.198M |
Date | Value |
---|---|
December 31, 2017 | 9.905M |
September 30, 2017 | 9.001M |
June 30, 2017 | 13.34M |
March 31, 2017 | 12.51M |
December 31, 2016 | 14.76M |
September 30, 2016 | 14.45M |
June 30, 2016 | 20.88M |
March 31, 2016 | 26.55M |
December 31, 2015 | 14.42M |
September 30, 2015 | 18.82M |
June 30, 2015 | 23.37M |
March 31, 2015 | 27.85M |
December 31, 2014 | 32.28M |
September 30, 2014 | 35.80M |
June 30, 2014 | 14.92M |
March 31, 2014 | 18.35M |
December 31, 2013 | 12.60M |
September 30, 2013 | 14.24M |
June 30, 2013 | 7.70M |
March 31, 2013 | 11.24M |
December 31, 2012 | 13.81M |
September 30, 2012 | 16.16M |
June 30, 2012 | 13.64M |
March 31, 2012 | 15.56M |
December 31, 2011 | 17.79M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.188M
Minimum
Jun 2020
266.32M
Maximum
Dec 2023
107.61M
Average
96.37M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Cassava Sciences Inc | 188.97M |
Adverum Biotechnologies Inc | 168.03M |
Regenxbio Inc | 348.27M |
Editas Medicine Inc | 232.01M |
Apellis Pharmaceuticals Inc | 264.33M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 324.25M |
Total Liabilities (Quarterly) | 95.94M |
Current Ratio | 4.749 |
Net Debt Paydown Yield | 1.53% |